gvtcx

PARIS Trial Clinical Trials EDC system: A phase 2 study of PD-1 inhibition in Rheumatoid Arthritis, Ulcerative Colitis and Sjogrens syndrome

UNIVERSITY OF BIRMINGHAM Published 9 Dec 2021 Find a Tender

key details

Statuscomplete
Category (CPV) 48613000
RegionWest Midlands
Procedurelimited
OCIDocds-h6vhtk-02ff58

Award

SupplierValueDateStatus
Medidata Solutions International Limited · · active

description

The PARIS trial (Sponsored by the University of Birmingham) is an Investigator Initiated Trial which is funded by an industry collaborator. The trial is required to have a suitably compliant clinical trial database (electronic data capture (EDC) system) that is active and ready for use by January 2022. Funding is provided to support the trial to be compliant with additional regulations (International Conference on Harmonization, the Food and Drug Administration (FDA) and European Medicines Agency (EMA) standards - specifically 21 CFR Part 11 guidance.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
9 Dec 2021 Voluntary ex-ante transparency (F15) Earlier regulations 030689-2021

more from UNIVERSITY OF BIRMINGHAM

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.